Engineering stock engaged in the business of providing engineering tools, components, and supply chain management services hits 20 percent upper circuit in the day’s trade upon posting its Q4FY24 results with a 148 percent jump in Net Profits.
With a market capitalization of Rs. 76 Crores, the shares of Bombay Metrics Supply Chain Limited hit a 20 percent upper circuit at Rs. 123.40, from its previous day’s close price of Rs. 102.85.
Its Revenue from Operations half yearly grew by 3 percent from Rs. 42.66 Crores in H1FY24 to Rs. 43.83 Crores in H2FY24 and it declined by 49 percent from Rs. 86.50 Crores in H2FY23 to Rs. 43.83 Crores in H2FY24.
Its Net profit half yearly grew by 148 percent from Rs. 96.19 Lakhs in H1FY24 to Rs. 2.38 Crores in H2FY24 and it declined by 29 percent from Rs. 3.34 Crores in H2FY23 to Rs. 2.38 Crores in H2FY24.
In Addition, the Board of Directors of Bombay Metrics Supply Chain Limited has recommended issuing a Final Dividend at 4.5 percent i.e., Rs. 0.45 per equity share with a face value of Rs. 10 per share for the financial year 2023-24.
Bombay Metrics Supply Chain Limited is engaged in the business of providing engineering tools, components, supply chain management services, and many more catering to various industries such as automotive, agriculture, lighting, electronic components, and many more.
Some of the products and services offered by the company are CNC machining, forging, stampings, global logistics management, assembly,3D scanning, rapid prototyping, flow simulation, and many more.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
